Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07362030
PHASE1

Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin

Sponsor: Guangdong Raynovent Biotech Co., Ltd

View on ClinicalTrials.gov

Summary

The drug-drug interaction study had been designed to investigate the effect of RAY1225 on the pharmacokinetics of digoxin, Rosuvastatin and

Official title: A Open-Label, Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2025-04-14

Completion Date

2026-03-30

Last Updated

2026-01-23

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

RAY1225

subcutaneous injection

DRUG

atorvastatin calcium tablet

Oral

DRUG

Metformin Tablets

Oral

DRUG

Warfarin Sodium Tablets

Oral

DRUG

Digoxin Tablets

Oral

Locations (1)

Dongguan People's Hospital

Dongguan, China